Discuss This Drug

Phenytoin

CHEBI:CHEBI_8107

Definition

A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5.

Chemical Information

Molecular Formula
C15H12N2O2
Molecular Mass
252.26800
Charge
0
SMILES
O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1
InChI
InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)
InChIKey
CXOFVDLJLONNDW-UHFFFAOYSA-N

Alternative Names

  • 5,5-Diphenyl-imidazolidine-2,4-dione
  • 5,5-diphenylimidazolidine-2,4-dione
  • 5,5-diphenylimidazolidine-2,4-dione
  • 5,5-diphenyltetrahydro-1H-2,4-imidazoledione
  • DILANTIN
  • fenitoina
  • PHENTYTOIN
  • phenytoin
  • phenytoine
  • phenytoinum

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

oboInOwl#hasDbXref
Wikipedia:Phenytoin
DRON_00010000
8183
core#notation
CHEBI:8107

Additional References

Wikipedia:Phenytoin

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
labeler_name
Taro Pharmaceuticals U.S.A., Inc
dosage_form
TABLET, CHEWABLE
application_number
ANDA040342
product_ndc
70518-4149
package_description
500 g in 1 JAR (62991-1691-3)
package_ndc
50090-5700-1
oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#hasDbXref
Wikipedia:Phenytoin
DRON_00010000
8183
oboInOwl#hasAlternativeId
CHEBI:100921
prefixIRI
CHEBI:8107
oboInOwl#id
CHEBI:8107
generic_name
phenytoin sodium
brand_name
Dilantin Infatabs
brand_name_base
Dilantin Infatabs
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_38633
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_27612
BFO_0000053
http://purl.obolibrary.org/obo/DRON_00723855
route
INTRAVENOUS
spl_id
074b7240-abe3-8c7b-e063-6294a90a0b30
listing_expiration_date
20241231
marketing_start_date
19790226
core#notation
CHEBI:8107
package_marketing_start_date
19790226
rxcui
1670353
manufacturer_name
Taro Pharmaceuticals U.S.A., Inc
unii
6158TKW0C5
spl_set_id
ca119a89-2394-4d34-8078-cd1fa4e8e2f1
active_ingredient_strength
125 mg/5mL
nui
N0000191267
pharm_class_epc
Anti-epileptic Agent [EPC]
pharm_class
Cytochrome P450 3A Inducers [MoA]
pharm_class_pe
Decreased Central Nervous System Disorganized Electrical Activity [PE]
active_ingredient_name
PHENYTOIN
pharm_class_moa
Cytochrome P450 3A Inducers [MoA]
upc
0300710007246
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_3209
RO_0001022
http://purl.obolibrary.org/obo/DOID_0040012
owl#annotatedSource
t304010
owl#someValuesFrom
t3004468